Primary Care POC Diagnostics Market Poised for Growth Amid Rising Demand for Early Disease Detection

The Primary Care Poc Diagnostics market research report is broadly bifurcated in terms of product type, application spectrum, end-user landscape, and competitive backdrop, which would help readers gain more impactful insights into the different aspects of the market. Under the competitive outlook, the report's authors have analyzed the financial standing of the leading companies operating across this industry. The gross profits, revenue shares, sales volume, manufacturing costs, and the individual growth rates of these companies have also been ascertained in this section. Our team has accurately predicted the future market scope of the new entrants and established competitors using several analytical tools, such as Porter's Five Forces Analysis, SWOT analysis, and investment assessment.

The Primary Care Poc Diagnostics market is expected to grow from an estimated USD 22.5 billion in 2024 to USD 29.9 billion in 2033, at a CAGR of 3.20%. The global primary care point-of-care (POC) diagnostics market is set for significant expansion, driven by the increasing need for early disease detection, the rising prevalence of chronic illnesses, and the demand for quick and accurate diagnostic solutions in primary care settings. As healthcare systems worldwide emphasize timely diagnosis, advancements in POC diagnostics are providing medical professionals with effective tools for rapid patient management.

The growing burden of chronic diseases is a major factor fueling market growth. According to a September 2023 World Health Organization (WHO) study, chronic illnesses account for 74% of all deaths globally, including conditions like diabetes, cancer, and cardiovascular diseases. Cardiovascular diseases alone were responsible for 17.9 million deaths. As awareness of early disease detection increases, the demand for POC diagnostic technologies is expected to surge.

Request a Sample Report with Table of Contents and Figures to click Here: @ https://www.emergenresearch.com/public/request-sample/3776

Competitive Landscape

The report presents a holistic investigation of the Primary Care Poc Diagnostics business mechanism and growth-oriented approaches undertaken by the leading companies operating in this market. The report highlights the numerous strategic initiatives, such as new business deals and collaborations, mergers & acquisitions, joint ventures, product launches, and technological upgradation, implemented by the leading market contenders to set a firm foot in the market. Hence, this section is inclusive of the company profiles of the key players, total revenue accumulation, product sales, profit margins, product pricing, sales & distribution channels, and industry analysis.

Leading Players Profiled in the Report Include:

Technological innovations are further propelling the market forward. Companies in the primary care POC diagnostics industry are integrating artificial intelligence (AI) to enhance test accuracy and efficiency. AI-powered systems provide real-time data analysis, offering instant insights to healthcare professionals while reducing the reliance on specialized expertise. These advancements facilitate early disease detection and personalized treatment, leading to improved patient outcomes. In October 2023, GE HealthCare introduced the Enhanced Venue Family of AI-powered point-of-care ultrasound scanners, which assist medical professionals in obtaining high-quality cardiac images in real time. This is expected to drive market growth in the coming years.

Market Drivers: Technological Advancements in POC Testing

The rapid evolution of POC testing applications is playing a crucial role in market expansion. Companies are developing multi-diagnostic devices that allow clinicians to conduct multiple tests using a single tool, enabling faster diagnosis and improved patient care. A notable example is Cipla's Cippoint, a point-of-care testing instrument launched in January 2023. Cippoint provides test results in three to fifteen minutes and covers a wide range of diagnostic areas, including thyroid function, metabolism, coagulation, inflammation, and heart conditions. Certified by the European In-Vitro Diagnostic Device Directive (CE IVD), this tool is expected to contribute to market growth by offering reliable and efficient diagnostic solutions.

Market Restraints: High Costs and Accuracy Concerns

Despite its promising growth, the primary care POC diagnostics market faces challenges, including high device costs and concerns over test accuracy. While POC testing kits offer several benefits, their widespread adoption is hindered by the substantial cost of equipment. Additionally, inadequate healthcare infrastructure in developing nations creates connectivity issues, requiring manual input of patient data, which can lead to errors and increased testing expenses. A WHO report from January 2023 projected a decline in the global healthcare workforce, particularly in low- and middle-income countries, which could further challenge the market's growth.

To Read More About The Report, Visit @https://www.emergenresearch.com/public/industry-report/primary-care-poc-diagnostics-market

Market Segmentation: Glucose Monitoring Products Lead Revenue Growth

The primary care POC diagnostics market is segmented into various product categories, including glucose monitoring products, COVID-19 testing kits, cardiometabolic monitoring products, infectious disease testing, coagulation monitoring, pregnancy and fertility testing, and cancer marker testing.

Among these, glucose monitoring products dominated the market in 2024, driven by the rising prevalence of diabetes. The WHO reported in April 2023 that type 2 diabetes affects over 95% of people with diabetes, increasing the demand for self-monitoring glucose testing devices. In response, companies are developing innovative solutions that allow individuals to track their glucose levels conveniently.

Meanwhile, the tumour/cancer marker testing segment is projected to experience the fastest growth, fueled by the increasing number of cancer cases and the growing demand for early detection tools. In 2022, there were 20 million new cancer cases worldwide, resulting in 9.7 million deaths. Cancer marker tests help detect various cancers, including prostate, liver, and stomach cancer. In October 2021, Boditech Med Inc. launched three new tumour markers to enhance cancer diagnostics. These advancements are expected to contribute to the segment's rapid growth in the coming years.

Segmentation

By Mode of Purchase Outlook (Revenue, USD Million; 2020-2033)

OTC Testing Products

Prescription-based Testing Products

By Platform Outlook (Revenue, USD Million; 2020-2033)

Lateral Flow Assays

Immunoassays

Microfluidics

Dipsticks

Molecular Diagnostic

By Sample Outlook (Revenue, USD Million; 2020-2033)

Blood Samples

Urine Samples

Nasal & Oropharyngeal Swabs

Others

By Product Outlook (Revenue, USD Million; 2020-2033)

Glucose Monitoring Products

Covid-19 Products

Cardiometabolic Monitoring Products

Infectious Diseases Testing Products

Coagulation Monitoring Products

Pregnancy & Fertility Testing Products

Tumors /Cancer Maarker Testing Products

Others

By End User Outlook (Revenue, USD Million; 2020-2033)

Clinicial Laboratories

Ambulatory Care Facilities and Physicians' Offices

Pharmacies, Retail Clinics, and E-Commerce Platforms

Hospitals, Critical Care Centres, and Urgent Care Centers

Home care Settings and Self-testing

Others

Requesting A Customised Report @https://www.emergenresearch.com/public/request-for-customization/3776

The global Primary Care Poc Diagnostics market is classified into the following regions:

North America (the U.S., Canada)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Europe (the U.K., Italy, Germany, France, Rest of EU)

Asia-Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

The Middle East & Africa (Saudi Arabia, the U.A.E., South Africa, Rest of MEA)

Key Points Covered in This Section:

Regional contribution

Estimated revenue generation

Vital data and information about the consumption rate in all the leading regional segments

An expected rise in market share

Forecast growth in the overall consumption rate

Report Highlights:

Besides offering a vivid depiction of the global Primary Care Poc Diagnostics business sphere and its fundamental operations, the latest report provides the industrial chain analysis and list down the current and future market trends and growth opportunities.

The report includes information on the present and historical market scenarios, which helps forecast the market conditions over the next eight years (2020-2027).

The report scrutinizes the salient factors influencing the growth of the market in the near future.

The strategic marketing recommendations, crucial information related to the new market entrants, and expansion plans of various businesses are poised to provide the reader with a competitive edge in the market.

To Purchase Now, Click Here @https://www.emergenresearch.com/public/select-license/3776

We appreciate you reading our report. Please contact us if you need the most recent report customised in any way. Our team will work with you to ensure that the report is created in accordance with your needs.

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.